# Biomarker Discovery for Suicide Precision Circuit Therapeutics

> **NCT07723066** · — · NOT_YET_RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Suicidal Thoughts and Behaviors
- Major Depressive Episode (MDE)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07723066
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2029-07
- **Final completion:** 2030-08-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07723066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07723066, "Biomarker Discovery for Suicide Precision Circuit Therapeutics". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07723066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*